Microglia-derived neuroinflammatory pathways in neuropathic pain

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Neuropathic pain (NP) is a debilitating chronic pain condition arising from nervous system damage.
• Microglia play a crucial role in NP initiation and progression, but mechanisms are not fully understood.
• Current NP treatments are limited, significantly impacting patient quality of life.

Purpose of the Study:

• To review the role of microglia in neuropathic pain.
• To explore key signaling pathways (NF-κB, PI3K/Akt/mTOR, p38MAPK, JAK2/STAT3, Nrf2/HO-1) involved in microglial activation.
• To summarize current and prospective microglia-targeted therapies for NP.

Main Methods:

• Literature review of recent research on microglial activation in neuropathic pain.
• Analysis of key molecules within major signaling pathways.
• Summary of drug, compound, and non-invasive treatment applications.

Main Results:

• Identified critical signaling pathways (NF-κB, PI3K/Akt/mTOR, p38MAPK, JAK2/STAT3, Nrf2/HO-1) mediating microglial activation in NP.
• Detailed the interplay between microglial phenotype, inflammatory processes, and NP.
• Highlighted potential therapeutic agents and non-invasive strategies targeting microglia.

Conclusions:

• Microglia are central to neuropathic pain pathogenesis.
• Understanding these signaling pathways provides a basis for developing novel microglia-targeted NP therapies.
• Further research into these pathways and treatments holds promise for improving NP management.